Next Article in Journal
Chronic Lead Exposure in Adult Mice: Associations with miR-671/CDR1as Regulation, NF-κB Signaling, and Alzheimer’s Disease-like Pathology
Next Article in Special Issue
Per- and Polyfluoroalkyl Substances (PFAS) Affect Female Reproductive Health: Epidemiological Evidence and Underlying Mechanisms
Previous Article in Journal
Microfibers in the Diet of a Highly Aerial Bird, the Common Swift Apus apus
Previous Article in Special Issue
Temporal Trend of Serum Perfluorooctanoic Acid and Perfluorooctane Sulfonic Acid among U.S. Adults with or without Comorbidities in NHANES 1999–2018
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Toxics
Volume 12
Issue 6
10.3390/toxics12060409
toxics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Leukocyte Telomere Length Mediates the Associations between Blood Lead and Cadmium with Hypertension among Adults in the United States: A Cross-Sectional Study

by
Changping Ouyang
1,†,
Yinan Yang
2,†,
Jinhua Pan
1,
Heming Liu
1,
Xuemei Wang
1,
Shengze Zhou
1,
Xiaoru Shi
1,
Yanxia Zhang
1,
Dan Wang
1 and
Xiaobin Hu
1,*
1
Institute of Epidemiology and Health Statistics, School of Public Health, Lanzhou University, No. 199 Donggang West Road, Chengguan District, Lanzhou 730000, China
2
The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai 519000, China
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Toxics 2024, 12(6), 409; https://doi.org/10.3390/toxics12060409
Submission received: 24 April 2024 / Revised: 23 May 2024 / Accepted: 26 May 2024 / Published: 3 June 2024
(This article belongs to the Special Issue Traditional and Emerging Pollutants: Human Exposure Profiles and Health Effects)
Browse Figures
Versions Notes

Abstract

:
There is evidence to support the links between lead and cadmium exposure with hypertension and also with leukocyte telomere length (LTL). The objective of this study is to investigate the role that LTL may play in the relationship between lead and cadmium exposure and hypertension. This study consisted of 3718 participants from the National Health and Nutrition Examination Survey (NHANES) 1999–2002. Logistic regression was used to analyze the relationship between blood metals with hypertension, and the mediating model was used to evaluate the mediating effect of LTL. In the fully adjusted model, both blood lead and cadmium ln-transformed concentrations were significantly positively associated with hypertension risk, as were all quartiles of blood lead. Additionally, we observed positive linear dose–response relationships with hypertension by restricted cubic spline analysis (both p overall < 0.001, p non-linear = 0.3008 for lead and p non-linear = 0.7611 for cadmium). The ln-transformed blood lead and cadmium concentrations were associated with shorter LTL. LTL was inversely related to hypertension and the OR was 0.65 (95% CI: 0.47 to 0.89). Furthermore, LTL had mediating effects on the associations of blood lead and cadmium with hypertension risk, and the mediation proportions were 2.25% and 4.20%, respectively. Our findings suggested that exposure to lead and cadmium raised the risk of hypertension, while LTL played as a mediating factor.

1. Introduction

Considering a major risk factor for dementia, chronic renal disease, and cardiovascular disorders, hypertension contributes significantly to the worldwide burden of disease [1]. Elevated blood pressure has also been linked to premature death. Between 1990 and 2015, the global death toll related to blood pressure increased dramatically, with an estimated 770 to 10.4 million deaths per year due to elevated blood pressure, and 10.7 million deaths in 2015 attributable to systolic blood pressure ≥ 110–115 mmHg, accounting for 19.2% of all deaths [2]. In 1990, there were 650 million hypertensive individuals aged 30–79; by 2019, that number had risen to 1.28 billion, and the global age-standardized prevalence of hypertension was more than 30%. There have been significant global gaps in the diagnosis, treatment, and disease burden of hypertension over the past three decades [3].
Lead and cadmium are hazardous environmental elements that may have adverse effects on human health. The general public is mostly exposed to tiny amounts of lead, cadmium, and other toxic metals through the following three ways: air inhalation, water and food contaminated toxic metal intake, and skin contact [4]. Exposure to toxic metals leads to oxidative stress, which can result in peroxidation of lipids, modification of proteins, damage to deoxyribonucleic acid (DNA), and other issues [5]. Lead and cadmium exposure have an influence on some diseases, including diabetes [6], hypertension [7], kidney disease [8], and other cardiovascular diseases (CVDs) [9]. As demonstrated by earlier research, exposure to either lead or cadmium elevates blood pressure and raises hypertension risk, and combined exposure is more significantly associated with elevated blood pressure [10,11]. Lanphear B.P. et al. reported that even low-level lead exposure, an important but largely overlooked risk factor, increased the risk of death for CVD [12]. Due to widespread and persistent metal pollution, environmental exposure to toxic metals remains an important public health issue affecting population health.
Telomeres are chromosome structures located at the ends of linear chromosomes that sustain genomic stability by preventing the loss of DNA sequences, avoiding end-to-end chromosome fusion, and distinguishing between DNA breaks and linear ends of chromosomes [13]. Telomerase is a DNA polymerase dependent on ribonucleic acid (RNA), and the biosynthesis of telomeres depends on telomerase [14]. Telomere and telomerase have an important impact on hypertension [15,16]. Previous studies have indicated that leukocyte telomere length (LTL) is an effective indicator of vascular aging and related diseases [17,18]. Exposure to lead and cadmium may induce oxidative stress, which may affect telomere length [19]. Telomere length has been found to be strongly and independently correlated with environmental exposure to cadmium [20]. Thus, exposure to lead and cadmium influences telomere length alterations, which are linked to blood pressure levels. Nevertheless, it is unclear how LTL affects the relationship between blood pressure and exposure to lead and cadmium.
This cross-sectional study was carried out based on data obtained from the National Health and Nutrition Examination Survey (NHANES) for the years 1999–2002. This study aimed to examine the association between lead and cadmium exposure and hypertension and investigate the potential effect of telomere length in the general population of the United States.

2. Materials and Methods

2.1. Study Population

NHANES is a cross-sectional study program to assess the health and nutrition status of adults and children in the United States. Data from the NHANES cycles of 1999–2000 and 2001–2002 were utilized. Among 21,004 subjects who were interviewed, we excluded those aged <20 years (n = 10,713) and being pregnant (n = 600), without blood lead or cadmium concentrations or LTL (n = 2317), and missing covariates (n = 3656). This study finally included a total of 3718 participants (Figure 1).

2.2. Exposure Measurement

Blood lead and cadmium concentrations were measured in accordance with published laboratory methods by the National Center for Environmental Health. Quantification of cadmium and lead is based on measuring the amount of light absorbed by ground-state atoms of the metals at 228.8 nm and 283.3 nm, respectively, from sources such as electrodeless discharge lamps (EDLs) or hollow cathode lamps (HCLs). Reconstituted human blood, bovine blood quality control pools, and aqueous standards are diluted using a matrix modifier (ammonium phosphate, triton X-100, and nitric acid). A PerkinElmer Model SIMAA 6000 simultaneous multi-element atomic absorption spectrometer with Zeeman background correction is utilized for assessing the levels of lead and cadmium [21,22]. In the study we conducted, the blood lead was reported in μg/dL and the cadmium in μg/L. The limits of detection (LODs) and distribution of blood lead and cadmium are shown in Supplementary Table S1. Quantities of 0.3 μg/dL and 0.3 μg/L were the LODs for blood lead and blood cadmium, respectively [23]. In total, 0.4% (n = 14) and 22.2% (n = 826) of the researchers found lower LODs for blood lead and cadmium, respectively. The LOD divided by √2 was used to substitute values that were lower than the LOD.

2.3. LTL Measurement

The LTL experiment was performed in Dr. Elizabeth Blackburn’s laboratory. Quantitative polymerase chain reaction (PCR) was applied to quantify LTL relative to standard reference DNA (T/S ratio). To calculate the conversion from T/S ratio to bp, telomeric restriction fragment (TRF) length from Southern blot analysis and T/S ratios were compared using DNA samples from the human diploid fibroblast cell line IMR90 at different population doublings [24,25]. The calculation was 2413 × (T/S) + 3274.

2.4. Outcome Ascertainment

All blood pressures (systolic and diastolic) were measured at the mobile examination center (MEC) by trained staff using a mercury sphygmomanometer on the right arm. After 5 min of calm relaxation, the eligible individuals had blood pressure taken 3 or 4 times [26,27]. The reported average of multiple measurements was used for analysis. If the researcher satisfied at least one of the following requirements, hypertension was taken into consideration: (1) a minimum diastolic blood pressure of 80 mmHg or a minimum systolic blood pressure of 130 mmHg; (2) self-reported physician’s diagnosis of hypertension; (3) currently taking medication for hypertension [28].

2.5. Covariates

We selected several covariates by referring to the covariates used in some previous studies on hypertension as potential confounders. All covariates can be divided into sociodemographic status, behaviors related to healthy lifestyle, the presence of other diseases, sex (male or female), age (<65 years or ≥65 years), race/ethnicity (Non-Hispanic White, Non-Hispanic Black, other Hispanic, or other race), marital status (married/living with partner, widowed/divorced/separated, or never married), educational attainment (less than 9th grade, 9–11th grade, high school grade/GED or equivalent, some college or AA degree, or college graduate or above), poverty income ratio (PIR, <1, 1–3, or >3) [29], family history of hypertension (yes or no), smoking status (never, former smoker, or current smoker) [30], alcohol consumption (yes or no), average daily energy intake (≤1527, 1528–2055, 2055–2732, or >2732 kcal), physical activity (none, moderate, or vigorous), body mass index (BMI, ≤25.0, 25.1–29.9, or ≥30.0 kg/m2), cardiovascular diseases (CVDs, yes or no), and diabetes (yes or no). According to the U.S. Census Bureau, PIR was an index of socioeconomic status that was calculated by dividing a family’s self-reported income by the poverty guideline the threshold. The definition of a smoker was as follows: a current smoker was one who smokes more than 100 cigarettes in their lifetime; a former smoker was one who smokes more than 100 cigarettes in their lifetime but does not smoke now; and a never smoker never smoked more than 100 cigarettes in their lifetime. The alcohol consumption was categorized by 12 drinks/year [31]. Participating in any kind of moderate or vigorous activity, exercise, or fitness for less than 10 min a week was not considered physical activity. Diabetes was identified by measuring glycosylated hemoglobin [HbA1c] ≥ 6.5%23 or by self-reported current use of insulin or oral hypoglycemic medications [32]. CVD was regarded as the self-reported diagnosis by a physician of heart disease, stroke, angina pectoris, congestive heart failure, and heart attacks [33].

2.6. Statistical Analysis

In order to summarize the population’s demographic features, descriptive statistics were used. The continuous variables were expressed as mean ± standard deviation ( x ¯ ± s), the categorical variables were expressed as percentages (%), and we utilized the t-test and the Chi-square test to compare the hypertensive and non-hypertensive population.
With three models, binary logistic regression analysis was utilized to explore the association between lead and cadmium exposure and hypertension risk, as well as the association between LTL and hypertension risk. Model 1 did not involve any covariates. Model 2 was adjusted for sex, age, race/ethnicity, marital status, education, poverty/income ratio, family history of hypertension, smoking status, alcohol consumption, average daily energy intake, physical activity, and BMI. Model 3 further incorporated CVD and diabetes. Given the right-skewed distribution of blood lead and cadmium concentrations, metal content was converted to natural logarithm (ln), with a distribution similar to normal. The lowest quartile array was selected as the reference group, and the patients were grouped based on the quartiles of blood lead and blood cadmium concentrations. Then, hypertension OR values and 95% confidence intervals (95% CIs) were calculated. By considering the median of each quartile as a continuous variable in the model, the linear trend test was performed. By fitting three knots (ln-transformed 25th, 50th, and 75th percentiles), limiting the cubic spline in the range among the 5th and 95th percentiles, the dose–response associations between blood lead and blood cadmium levels and the risk of hypertension were further examined in Model 3. Non-linearity was assessed by likelihood ratio tests.
To assess the relationship between lead and cadmium exposure and LTL, linear regression was used. Since LTL was not uniformly distributed, natural ln transformation was applied. The two previously described types of lead and cadmium levels were also utilized to calculate the percent difference and 95% CIs for LTL.
To determine the possible impacts of LTL on the correlations between blood lead and cadmium levels and the risk of hypertension, a model using IE (indirect effect) divided by TE (total effect) was utilized to determine the proportion of mediation. IE was the effect of lead and cadmium exposure on hypertension through LTL, and DE was the effect of lead and cadmium exposure on hypertension without LTL. In the mediation analysis, the quasi-Bayes Monte Carlo method was used, and 1000 simulations were performed based on the normal approximation.
All statistical analyses were performed with R software (version 4.1.3, Copyright The R Foundation for Statistical Computing). A two-sided p value of <0.05 was considered statistically significant.

3. Results

3.1. Characteristics of Participants

Supplementary Table S2 shows the demographic characteristics of participants with and without hypertension. The population was 56.8% male and 43.2% female. There were 1907 participants with hypertension (51.3%) among the 3718 participants aged over 20 years, and 60.2% were men. With the exception of PIR, there were statistical differences between participants with and without hypertension in terms of sex, age, race/ethnicity, marital status, educational attainment, smoking status, alcohol consumption, average daily energy intake, physical activity, BMI, CVD, and diabetes. In comparison to non-hypertension patients, hypertensive participants exhibited shorter LTL and higher concentrations of lead and cadmium.

3.2. Blood Metal Concentrations and Hypertension Risk

To examine the relationships between lead and cadmium levels and the risk of hypertension, we employed three different models. The crude and adjusted ORs (95% CIs) of hypertension for blood lead and cadmium concentrations are summarized in Table 1. We observed that there was a statistically significant correlation between ln-transformed blood lead concentrations and blood pressure in every model. The risk of hypertension was higher in the other quartiles of blood lead levels than in the first quartile (both p < 0.05). As a comparison to the reference group, the calculated ORs (95% CIs) of hypertension in Model 3 were 1.40 (1.14 to 1.72), 1.52 (1.23 to 1.89), and 2.02 (1.59 to 2.56) for the second to fourth quartiles of blood lead levels (p value for trend < 0.001). As for ln-transformed blood cadmium concentration, no significant association was found in Model 1, and significantly positive associations were found after adjusting by covariates (Model 2 and Model 3). In Model 3, the calculated ORs (95% CIs) of hypertension correlates with the blood cadmium levels’ second to fourth quartiles were 1.10 (0.89 to 1.36), 1.62 (1.32 to 2.00), and 1.54 (1.18 to 2.01) when compared to the reference group (p value for trend < 0.001).
The multivariate-adjusted restricted cubic spline analyses showed positive associations with the hypertension risk for both ln-transformed blood lead and cadmium concentrations (all p for overall < 0.0001, p for non-linearity of 0.3008 and 0.7611, respectively) (Figure 2).

3.3. Blood Metal Concentrations and LTL

Based on linear regression, Figure 3 displays the percent difference (95% CIs) of LTL for blood lead and cadmium concentrations. We discovered statistically significant negative relationships for both ln-transformed blood lead and cadmium contents in all models. In three models, the LTL of the second to fourth quartiles of blood cadmium levels was lower than that of the reference group (all p < 0.05). As for blood lead levels, we found the same result only in the unadjusted model (Model 1) (both p < 0.05). The second quartile showed no significant correlation with LTL once variables were taken into account (Model 2 and Model 3), while the third and fourth quartiles did.

3.4. LTL and Hypertension Risk

Table 2 displays the associations of LTL and hypertension risk by logistic regression. We observed that hypertension risk was decreased with increasing LTL in all models (both p < 0.05). The estimated ORs (95% CIs) of hypertension associated with LTL in three models were 0.26 (0.19 to 0.34), 0.62 (0.45 to 0.85), and 0.65 (0.47 to 0.89), respectively.

3.5. Mediation Analyses

Furthermore, for the purpose of evaluating the potential effects of LTL, we performed a simple mediation effect analysis. The findings demonstrated that correlations between exposure to lead and cadmium with the development of hypertension were significantly mediated by LTL. The value of mediating effects was 0.0021 and 0.0034, and the proportion of mediation was 2.25% and 4.20%, respectively (Figure 4).

4. Discussion

In our study, we discovered that blood lead and cadmium had substantially positive relationships with hypertension in the fully adjusted model. For every 1 μg/dL higher blood lead concentration and every 1 μg/L higher blood cadmium concentration, the risk of hypertension increased by 46% and 35%, respectively. Those with blood lead and cadmium concentrations in the highest quartiles had about 102% and 54% higher hypertension risk than those in the lowest quartile. Moreover, exposure to lead and cadmium and hypertension risk may be mediated by LTL.
The findings of this study are in line with earlier research on the connection between exposure to lead and cadmium and hypertension. Wu et al. declared that blood lead and cadmium had positive relationships with hypertension risk and also with diastolic and systolic pressure [34]. According to a study utilizing the NHANES 1999–2018 database, hypertension prevalence rose by 12% in the group with the highest blood lead concentration quartiles compared that with the lowest quartiles [35]. Meanwhile, the same association was shown between blood cadmium and hypertension risk in a study based on the KNHANES (Korean National Health and Nutrition Examination Survey) database [11]. Furthermore, it was reported that blood cadmium had a stronger association than lead with elevated blood pressure and hypertension risk in research based on the KNANES [10].
Lead and cadmium are hazardous substances that exist widely in the environment and have various adverse effects on human health [5]. Although the mechanisms of lead and cadmium toxicity for humans are not yet clear, several studies have explored some possible mechanisms. Lead and cadmium may induce endothelial dysfunction, specifically by enhancing the generation of reactive oxygen species, which can decrease nitric oxide bioavailability, increase vasoconstrictive activity, and eventually lead to the occurrence and development of hypertension [19,36,37]. Lead and cadmium also cause dysregulation of the renin–angiotensin–aldosterone system and increase levels of norepinephrine, which affects vascular smooth muscle, thus promoting vascular constriction [36,38]. Furthermore, there are idiosyncratic mechanisms in lead-induced hypertension. Lead is a calcium-like element that competes with calcium for transportation through endoplasmic reticulum channels and pumps, which impacts vascular resistance [19,37].
Consistent with earlier studies, a significantly negative association was found between blood cadmium and LTL. A prior study based on the NHANES reported that a doubled increase in blood cadmium was linked to a 2.46% reduction in LTL and the highest quartile of blood cadmium was associated with 5.54% shorter LTL compared with the lowest quartile [20]. In contrast, no association was found between blood lead and LTL [20]. In agreement with the above research, Wu et al. reported the same results about blood lead and LTL [39]. However, it is worth noting that a significantly negative association was also found between blood lead and LTL in our study, which was different from previous studies. A prospective U.S. prebirth cohort observed that exposure to lead and cadmium during pregnancy were inversely related to newborn relative LTL, whereas our participants were non-pregnant [40]. The effects of lead and cadmium on LTL might be induced through inflammation and oxidative stress, which are caused by an imbalance in the generation of reactive oxygen species (ROS) and detoxification [41,42]. All in all, further research is needed on the relationship between lead exposure and LTL.
A negative association was observed between LTL and hypertension risk, in line with some previous studies. Cheng et al., for example, reported that the LTL of essential hypertension patients was significantly shorter, which might be due to the defective TERT (telomerase reverse transcriptase) and TERC (internal RNA template) expression in leukocytes, which is responsible for maintaining and prolonging LTL and plays a role in regulating tissue repair and regeneration [43]. This was also reported in a community-based study in Lebanon and a study about coal miners in China [44,45]. The mechanism by which telomere length causes hypertension is still unclear. In addition to the above mentioned possible mechanism inferred by Chen et al., other possible mechanisms are summarized in a review [46]. Firstly, LTL shortening may lead to cellular senescence. LTL shortening accelerates the aging process of vascular endothelial cells, increases cholesterol deposition, forms plaque, and then leads to atherosclerosis [47]. Aging vascular smooth muscle cells (VSMCs) in atherosclerotic plaques are limited in their ability to proliferate and have increased matrix-degrading enzyme activity that promotes fiber cap thinning and plaque rupture, which can lead to subsequent thrombosis, myocardial infarction, or stroke [46]. In addition, the repair mechanism of vascular atherosclerosis relies on endothelial progenitor cells (EPCs), and LTL shortening limits the number and function of EPCs, which in turn impair the replication potential of the damaged part of the vasculature [46,48]. Secondly, the shortening of LTL reduces the regenerative ability of cardiomyocytes, and the accumulation of old dead cells eventually leads to cardiac pumping failure [49]. Finally, shortening of LTL decreases leukocyte function and causes inflammatory response. During this process, a large number of CD8+ T cells are present, and their secretion of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) causes low-grade systemic inflammation, which is a pathogenic factor for atherosclerosis and cardiovascular diseases [42]. However, serval studies have reported different conclusions. A Mendelian randomization study declared that LTL had a positive association with hypertension risk, which was opposite to the other CVDs, such as myocardial infarction, ischemic heart disease, coronary atherosclerosis, and stroke [50]. Additionally, it has also been reported that there was no association between LTL and blood pressure or hypertension risk [51,52]. The relationship between LTL and hypertension was uncertain, and the current conclusions about it were completely contradictory. Hence, it is necessary to conduct more research to explore its specific relationship.
In mediation analysis, LTL had mediating effects on the associations of blood lead and cadmium with hypertension risk, even though the mediation proportions were only 2.25% and 4.20%, respectively. This finding suggested that in addition to their direct effects on the development and progression of hypertension, blood lead and cadmium may also have indirect effects by accelerating cell senescence. This mediating effect of LTL has been demonstrated in other diseases or indicators to assess health status. Chen et al. observed that LTL mediated the relationships between urinary metals and osteoarthritis risk, with a mediated proportion of 9.81% [53]. Zhang et al. found the same in the relationships between lead and cadmium with blood glucose [54], and Li et al. also found it in the relationship between lead and eGFR (glomerular filtration rate) [55]. To our knowledge, this may be the first study based on the NHANES database to examine the mediating role of LTL on the associations between blood metals and hypertension risk.
This study has several strengths, as follows: Firstly, a substantial inverse correlation between blood lead and LTL was discovered, which was different from previous studies. Additionally, the subjects in this study were from a non-occupationally exposed population that was exposed to low doses, making it possible to investigate the consequences of low levels of exposure.
There are also some limitations to this study. First, its cross-sectional nature makes it impossible to infer causality. Second, the concentration of blood lead and cadmium measured at one time may not fully reflect the actual exposure, and it is affected by metabolism. Third, even though we adjusted for confounding factors from three aspects, we were not able to completely adjust for all confounding factors, such as unknown or residual confounding factors.

5. Conclusions

In summary, our study revealed a link between lead and cadmium exposure with a higher risk of hypertension as well as a lower LTL. Moreover, LTL shortening was related to increased hypertension risk. On the basis of the above findings, mediation analyses suggested that LTL may be a mediating factor in the association between exposure to lead and cadmium and hypertension. The exact mechanism behind these associations is still unclear, and it is critical that more investigation into the mechanisms is carried out in the future in order to better explain these associations.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/toxics12060409/s1, Table S1: Limits of detection (LODs) and distributions for blood lead and cadmium among participants in NHANES 1999–2002 (n = 3718); Table S2: Basic characteristics of participants among U.S. adults, NHANES 1999–2002.

Author Contributions

Conceptualization, C.O. and Y.Y.; Methodology, C.O. and Y.Y.; Software, C.O. and J.P.; Visualization, C.O. and J.P.; Writing—Original draft preparation, C.O., H.L., X.W., S.Z., X.S.; Y.Z., and D.W. Data curation, C.O.; Writing—Reviewing, J.P.; Supervision, Y.Y. and X.H. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the Natural Science Foundation of Gansu Province, China (no. 23JRRA0969).

Institutional Review Board Statement

This study was conducted in accordance with the Declaration of Helsinki and approved by the U.S. National Center for Health Statistics (NCHS) Research Ethics Review Board. No further ethical approval is required.

Informed Consent Statement

Informed consent was obtained from all subjects involved in this study.

Data Availability Statement

The data are publicly available on the NHANES website: https://www.cdc.gov/nchs/nhanes/Index.htm (accessed on 24 April 2024).

Acknowledgments

The authors thank the National Center for Health Statistics of the Centers for Disease Control and Prevention for sharing the data.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Zhou, B.; Perel, P.; Mensah, G.A.; Ezzati, M. Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nat. Rev. Cardiol. 2021, 18, 785–802. [Google Scholar] [CrossRef] [PubMed]
  2. Collaborators GBDCoD. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018, 392, 1736–1788. [Google Scholar] [CrossRef] [PubMed]
  3. Zhou, B.; Carrillo-Larco, R.M.; Danaei, G.; Riley, L.M.; Paciorek, C.J.; Stevens, G.A.; Gregg, E.W.; Bennett, J.E.; Solomon, B.; Singleton, R.K.; et al. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: A pooled analysis of 1201 population-representative studies with 104 million participants. Lancet 2021, 398, 957–980. [Google Scholar] [CrossRef] [PubMed]
  4. Shi, L.; Yuan, Y.; Xiao, Y.; Long, P.; Li, W.; Yu, Y.; Liu, Y.; Liu, K.; Wang, H.; Zhou, L.; et al. Associations of plasma metal concentrations with the risks of all-cause and cardiovascular disease mortality in Chinese adults. Environ. Int. 2021, 157, 106808. [Google Scholar] [CrossRef] [PubMed]
  5. Solenkova, N.V.; Newman, J.D.; Berger, J.S.; Thurston, G.; Hochman, J.S.; Lamas, G.A. Metal pollutants and cardiovascular disease: Mechanisms and consequences of exposure. Am. Heart J. 2014, 168, 812–822. [Google Scholar] [CrossRef]
  6. Wang, B.; Chen, C.; Zhang, W.; Chen, Y.; Xia, F.; Wang, N.; Lu, Y. Exposure to lead and cadmium is associated with fasting plasma glucose and type 2 diabetes in Chinese adults. Diabetes Metab. Res. Rev. 2022, 38, e3578. [Google Scholar] [CrossRef] [PubMed]
  7. Gambelunghe, A.; Sallsten, G.; Borne, Y.; Forsgard, N.; Hedblad, B.; Nilsson, P.; Fagerberg, B.; Engstrom, G.; Barregard, L. Low-level exposure to lead, blood pressure, and hypertension in a population-based cohort. Environ. Res. 2016, 149, 157–163. [Google Scholar] [CrossRef]
  8. Orr, S.; Bridges, C. Chronic Kidney Disease and Exposure to Nephrotoxic Metals. Int. J. Mol. Sci. 2017, 18, 1039. [Google Scholar] [CrossRef]
  9. Wang, K.; Mao, Y.; Liu, Z.; Li, Y.; Li, Z.; Sun, Y.; Ding, Y.; Liu, X.; Hong, J.; Xu, D.; et al. Association of Blood Heavy Metal Exposure with Atherosclerotic Cardiovascular Disease (ASCVD) Among White Adults: Evidence from NHANES 1999–2018. Biol. Trace Elem. Res. 2022, 201, 4321–4333. [Google Scholar] [CrossRef]
  10. Lee, B.K.; Ahn, J.; Kim, N.S.; Lee, C.B.; Park, J.; Kim, Y. Association of Blood Pressure with Exposure to Lead and Cadmium: Analysis of Data from the 2008–2013 Korean National Health and Nutrition Examination Survey. Biol. Trace Elem. Res. 2016, 174, 40–51. [Google Scholar] [CrossRef]
  11. Ahn, J.; Kim, N.S.; Lee, B.K.; Park, J.; Kim, Y. Association of Blood Pressure with Blood Lead and Cadmium Levels in Korean Adolescents: Analysis of Data from the 2010-2016 Korean National Health and Nutrition Examination Survey. J. Korean Med. Sci. 2018, 33, e278. [Google Scholar] [CrossRef] [PubMed]
  12. Lanphear, B.P.; Rauch, S.; Auinger, P.; Allen, R.W.; Hornung, R.W. Low-level lead exposure and mortality in US adults: A population-based cohort study. Lancet Public Health 2018, 3, e177–e184. [Google Scholar] [CrossRef] [PubMed]
  13. de Lange, T. How Telomeres Solve the End-Protection Problem. Science 2009, 326, 948–952. [Google Scholar] [CrossRef] [PubMed]
  14. Shay, J.W. Telomeres and aging. Curr. Opin. Cell Biol. 2018, 52, 1–7. [Google Scholar] [CrossRef] [PubMed]
  15. Ma, L.; Li, Y.; Wang, J. Telomeres and essential hypertension. Clin. Biochem. 2015, 48, 1195–1199. [Google Scholar] [CrossRef] [PubMed]
  16. Liu, P.; Zhang, Y.; Ma, L. Telomere length and associated factors in older adults with hypertension. J. Int. Med. Res. 2019, 47, 5465–5474. [Google Scholar] [CrossRef] [PubMed]
  17. Zhang, W.; Chen, Y.; Wang, Y.; Liu, P.; Zhang, M.; Zhang, C.; Hu, F.B.; Hui, R. Short telomere length in blood leucocytes contributes to the presence of atherothrombotic stroke and haemorrhagic stroke and risk of post-stroke death. Clin. Sci. 2013, 125, 27–36. [Google Scholar] [CrossRef]
  18. Wilson, W.R.W.; Herbert, K.E.; Mistry, Y.; Stevens, S.E.; Patel, H.R.; Hastings, R.A.; Thompson, M.M.; Williams, B. Blood leucocyte telomere DNA content predicts vascular telomere DNA content in humans with and without vascular disease. Eur. Heart J. 2008, 29, 2689–2694. [Google Scholar] [CrossRef] [PubMed]
  19. Wu, X.; Cobbina, S.J.; Mao, G.; Xu, H.; Zhang, Z.; Yang, L. A review of toxicity and mechanisms of individual and mixtures of heavy metals in the environment. Environ. Sci. Pollut. Res. Int. 2016, 23, 8244–8259. [Google Scholar] [CrossRef]
  20. Zota, A.R.; Needham, B.L.; Blackburn, E.H.; Lin, J.; Park, S.K.; Rehkopf, D.H.; Epel, E.S. Associations of Cadmium and Lead Exposure With Leukocyte Telomere Length: Findings From National Health and Nutrition Examination Survey, 1999–2002. Am. J. Epidemiol. 2015, 181, 127–136. [Google Scholar] [CrossRef]
  21. Centers for Disease Control and Prevention (CDC): National Health and Nutrition Examination Survey 1999–2000 Data Documentation, Codebook, and Frequencies: Cadmium, Lead, Mercury, Cotinine & Nutritional Biochemistries (LAB06). Available online: https://wwwn.cdc.gov/Nchs/Nhanes/1999-2000/LAB06.htm (accessed on 22 May 2024).
  22. Centers for Disease Control and Prevention (CDC): National Health and Nutrition Examination Survey 2000–2001 Data Documentation, Codebook, and Frequencies: Cadmium, Lead, Mercury, Cotinine & Nutritional Biochemistries (LAB06). Available online: https://wwwn.cdc.gov/Nchs/Nhanes/2001-2002/L06_B.htm (accessed on 22 May 2024).
  23. Guallar, E.; Silbergeld, E.K.; Navas-Acien, A.; Malhotra, S.; Astor, B.C.; Sharrett, A.R.; Schwartz, B.S. Confounding of the Relation between Homocysteine and Peripheral Arterial Disease by Lead, Cadmium, and Renal Function. Am. J. Epidemiol. 2006, 163, 700–708. [Google Scholar] [CrossRef] [PubMed]
  24. Centers for Disease Control and Prevention: National Health and Nutrition Examination Survey 1999–2000 Data Documentation, Codebook, and Frequencies: Telomere Mean and Standard Deviation (Surplus) (TELO_A). Available online: https://wwwn.cdc.gov/Nchs/Nhanes/1999-2000/TELO_A.htm (accessed on 22 May 2024).
  25. Centers for Disease Control and Prevention: National Health and Nutrition Examination Survey 2001–2002 Data Documentation, Codebook, and Frequencies: Telomere Mean and Standard Deviation (Surplus) (TELO_B). Available online: https://wwwn.cdc.gov/Nchs/Nhanes/2001-2002/TELO_B.htm (accessed on 22 May 2024).
  26. Centers for Disease Control and Prevention: National Health and Nutrition Examination Survey 1999–2000 Data Documentation, Codebook, and Frequencies: Blood Pressure (BPX). Available online: https://wwwn.cdc.gov/Nchs/Nhanes/1999-2000/BPX.htm (accessed on 22 May 2024).
  27. Centers for Disease Control and Prevention: National Health and Nutrition Examination Survey 2000–2001 Data Documentation, Codebook, and Frequencies: Blood Pressure (BPX_B). Available online: https://wwwn.cdc.gov/Nchs/Nhanes/2001-2002/BPX_B.htm (accessed on 22 May 2024).
  28. Reboussin, D.M.; Allen, N.B.; Griswold, M.E.; Guallar, E.; Hong, Y.; Lackland, D.T.; Miller, E.R.; Polonsky, T.; Thompson-Paul, A.M.; Vupputuri, S. Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2018, 138, e595–e616. [Google Scholar] [CrossRef]
  29. Liu, Y.; Geng, T.; Wan, Z.; Lu, Q.; Zhang, X.; Qiu, Z.; Li, L.; Zhu, K.; Liu, L.; Pan, A.; et al. Associations of Serum Folate and Vitamin B12 Levels With Cardiovascular Disease Mortality Among Patients With Type 2 Diabetes. JAMA Netw. Open 2022, 5, e2146124. [Google Scholar] [CrossRef] [PubMed]
  30. Yang, J.; Yang, A.; Yeung, S.; Woo, J.; Lo, K. Joint Associations of Food Groups with All-Cause and Cause-Specific Mortality in the Mr. OS and Ms. OS Study: A Prospective Cohort. Nutrients 2022, 14, 3915. [Google Scholar] [CrossRef] [PubMed]
  31. Yang, J.; Chan, K.; Choi, C.; Yang, A.; Lo, K. Identifying Effects of Urinary Metals on Type 2 Diabetes in U.S. Adults: Cross-Sectional Analysis of National Health and Nutrition Examination Survey 2011–2016. Nutrients 2022, 14, 1552. [Google Scholar] [CrossRef]
  32. Kilpatrick, E.S.; Bloomgarden, Z.T.; Zimmet, P.Z. International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes. Diabetes Care 2009, 32, e159. [Google Scholar] [CrossRef]
  33. Zhang, N.-H.; Luo, R.; Cheng, Y.-C.; Ge, S.-W.; Xu, G. Leisure-Time Physical Activity and Mortality in CKD: A 1999–2012 NHANES Analysis. Am. J. Nephrol. 2020, 51, 919–929. [Google Scholar] [CrossRef]
  34. Wu, S.; Li, L.; Ji, G.; Xing, X.; Li, J.; Ma, A.; Wei, Y.; Zhao, D.; Huang, H.; Ma, W.; et al. Association of multi-metals with the risk of hypertension and the interaction with obesity: A cross-sectional study in China. Front. Public Health 2023, 11, 1090935. [Google Scholar] [CrossRef]
  35. Huang, Z. Association Between Blood Lead Level With High Blood Pressure in US (NHANES 1999–2018). Front. Public Health 2022, 10, 836357. [Google Scholar] [CrossRef]
  36. Angeli, J.K.; Cruz Pereira, C.A.; de Oliveira Faria, T.; Stefanon, I.; Padilha, A.S.; Vassallo, D.V. Cadmium exposure induces vascular injury due to endothelial oxidative stress: The role of local angiotensin II and COX-2. Free Radic. Biol. Med. 2013, 65, 838–848. [Google Scholar] [CrossRef]
  37. Vaziri, N.D. Mechanisms of lead-induced hypertension and cardiovascular disease. Am. J. Physiol. Heart Circ. Physiol. 2008, 295, H454–H465. [Google Scholar] [CrossRef] [PubMed]
  38. Morty, R.E.; Simões, M.R.; Ribeiro Júnior, R.F.; Vescovi, M.V.A.; de Jesus, H.C.; Padilha, A.S.; Stefanon, I.; Vassallo, D.V.; Salaices, M.; Fioresi, M. Acute Lead Exposure Increases Arterial Pressure: Role of the Renin-Angiotensin System. PLoS ONE 2011, 6, e18730. [Google Scholar] [CrossRef] [PubMed]
  39. Wu, Y.; Liu, Y.; Ni, N.; Bao, B.; Zhang, C.; Lu, L. High lead exposure is associated with telomere length shortening in Chinese battery manufacturing plant workers. Occup. Environ. Med. 2012, 69, 557–563. [Google Scholar] [CrossRef] [PubMed]
  40. Cowell, W.; Colicino, E.; Tanner, E.; Amarasiriwardena, C.; Andra, S.S.; Bollati, V.; Kannan, S.; Ganguri, H.; Gennings, C.; Wright, R.O.; et al. Prenatal toxic metal mixture exposure and newborn telomere length: Modification by maternal antioxidant intake. Environ. Res. 2020, 190, 110009. [Google Scholar] [CrossRef] [PubMed]
  41. Houben, J.M.J.; Moonen, H.J.J.; van Schooten, F.J.; Hageman, G.J. Telomere length assessment: Biomarker of chronic oxidative stress? Free Radic. Biol. Med. 2008, 44, 235–246. [Google Scholar] [CrossRef] [PubMed]
  42. Lichterfeld, M.; O’Donovan, A.; Pantell, M.S.; Puterman, E.; Dhabhar, F.S.; Blackburn, E.H.; Yaffe, K.; Cawthon, R.M.; Opresko, P.L.; Hsueh, W.-C.; et al. Cumulative Inflammatory Load Is Associated with Short Leukocyte Telomere Length in the Health, Aging and Body Composition Study. PLoS ONE 2011, 6, e19687. [Google Scholar] [CrossRef]
  43. Cheng, G.; Wang, L.; Dai, M.; Wei, F.; Xu, D. Shorter Leukocyte Telomere Length coupled with lower expression of Telomerase Genes in patients with Essential Hypertension. Int. J. Med. Sci. 2020, 17, 2180–2186. [Google Scholar] [CrossRef] [PubMed]
  44. Tamim, H.; Isma’eel, H.; Nakhoul, N.; Nasrallah, M.; Nasreddine, L.; Sleiman, F.; Zgheib, N.K. Short Telomere Length is Associated with Aging, Central Obesity, Poor Sleep and Hypertension in Lebanese Individuals. Aging Dis. 2018, 9, 77. [Google Scholar] [CrossRef]
  45. Yu, S.-N.; Chen, S.-Q.; Fan, G.-Q.; Pan, W.-Z.; Jia, J.; Wang, Q.; Ma, L.; Li, B.; Qiang, M.; Qiu, Y.-L.; et al. Relative Telomere Length in Peripheral Blood Cells and Hypertension Risk among Mine Workers: A Case-Control Study in Chinese Coal Miners. BioMed Res. Int. 2020, 2020, 5681096. [Google Scholar] [CrossRef]
  46. Yeh, J.-K.; Wang, C.-Y. Telomeres and Telomerase in Cardiovascular Diseases. Genes 2016, 7, 58. [Google Scholar] [CrossRef]
  47. Yegorov, Y.E.; Poznyak, A.V.; Nikiforov, N.G.; Starodubova, A.V.; Orekhov, A.N. Role of Telomeres Shortening in Atherogenesis: An Overview. Cells 2021, 10, 395. [Google Scholar] [CrossRef] [PubMed]
  48. Fadini, G.P.; Agostini, C.; Sartore, S.; Avogaro, A. Endothelial progenitor cells in the natural history of atherosclerosis. Atherosclerosis 2007, 194, 46–54. [Google Scholar] [CrossRef] [PubMed]
  49. Yeh, J.-K.; Lin, M.-H.; Wang, C.-Y. Telomeres as Therapeutic Targets in Heart Disease. JACC Basic Transl. Sci. 2019, 4, 855–865. [Google Scholar] [CrossRef] [PubMed]
  50. Deng, Y.; Li, Q.; Zhou, F.; Li, G.; Liu, J.; Lv, J.; Li, L.; Chang, D. Telomere length and the risk of cardiovascular diseases: A Mendelian randomization study. Front. Cardiovasc. Med. 2022, 9, 1012615. [Google Scholar] [CrossRef] [PubMed]
  51. Morgan, R.G.; Ives, S.J.; Walker, A.E.; Cawthon, R.M.; Andtbacka, R.H.I.; Noyes, D.; Lesniewski, L.A.; Richardson, R.S.; Donato, A.J. Role of arterial telomere dysfunction in hypertension: Relative contributions of telomere shortening and telomere uncapping. J. Hypertens. 2014, 32, 1293–1299. [Google Scholar] [CrossRef] [PubMed]
  52. Koriath, M.; Müller, C.; Pfeiffer, N.; Nickels, S.; Beutel, M.; Schmidtmann, I.; Rapp, S.; Münzel, T.; Westermann, D.; Karakas, M.; et al. Relative Telomere Length and Cardiovascular Risk Factors. Biomolecules 2019, 9, 192. [Google Scholar] [CrossRef] [PubMed]
  53. Chen, L.; Zhao, Y.; Liu, F.; Chen, H.; Tan, T.; Yao, P.; Tang, Y. Biological aging mediates the associations between urinary metals and osteoarthritis among U.S. adults. BMC Med. 2022, 20, 207. [Google Scholar] [CrossRef]
  54. Zhang, Y.; Guo, J.; Kang, H.; Han, Z. Mediating effect of telomere length on relationship between lead and cadmium coexposure and blood glucose. J. Environ. Occup. Med. 2022, 39, 841–848. [Google Scholar] [CrossRef]
  55. Li, Y.; Guo, J.; Gao, Y.; Kang, H. Mediating role of peripheral blood telomere length in relationship between environmental lead exposure and glomerular filtration rate. J. Occup. Environ. Med. 2023, 38, 1327–1332. [Google Scholar] [CrossRef]
Toxics 12 00409 g001
Figure 1. Flow chart of the selection process for eligible participants.
Figure 1. Flow chart of the selection process for eligible participants.
Toxics 12 00409 g001
Toxics 12 00409 g002
Figure 2. Adjusted restricted cubic spline for the association between blood lead (A) and cadmium (B) with hypertension. Model adjusted for sex, age, race/ethnicity, marital status, education, poverty/income ratio, family history of hypertension, smoking status, alcohol consumption, average daily energy intake, physical activity, BMI, CVD, and diabetes.
Figure 2. Adjusted restricted cubic spline for the association between blood lead (A) and cadmium (B) with hypertension. Model adjusted for sex, age, race/ethnicity, marital status, education, poverty/income ratio, family history of hypertension, smoking status, alcohol consumption, average daily energy intake, physical activity, BMI, CVD, and diabetes.
Toxics 12 00409 g002
Toxics 12 00409 g003
Figure 3. Percent difference (95% CIs) in LTL by lead and cadmium exposure.
Figure 3. Percent difference (95% CIs) in LTL by lead and cadmium exposure.
Toxics 12 00409 g003
Toxics 12 00409 g004
Figure 4. Estimated proportion of the association between metals and hypertension.
Figure 4. Estimated proportion of the association between metals and hypertension.
Toxics 12 00409 g004
Table 1. Odds ratios (95% CIs) for hypertension associated with blood lead and blood cadmium concentrations, NHANES 1999–2002.
Table 1. Odds ratios (95% CIs) for hypertension associated with blood lead and blood cadmium concentrations, NHANES 1999–2002.
Blood MetalsContinuousQ1Q2Q3Q4p for Trend *
Blood lead (μg/dL) ≤1.21.2–1.81.8–2.8>2.8
Model 11.71 (1.54, 1.90)1.00 (reference)1.56 (1.30, 1.88)1.93 (1.60, 2.33)2.66 (2.19, 3.24)<0.001
Model 21.43 (1.26, 1.63)1.00 (reference)1.38 (1.13, 1.70)1.48 (1.20, 1.83)1.96 (1.55, 2.48)<0.001
Model 31.46 (1.28, 1.66)1.00 (reference)1.40 (1.14, 1.72)1.52 (1.23, 1.89)2.02 (1.59, 2.56)<0.001
Blood cadmium (μg/L) ≤0.30.3–0.40.4–0.7>0.7
Model 11.10 (0.99, 1.22)1.00 (reference)1.19 (0.98, 1.44)1.65 (1.39, 1.97)1.13 (0.94, 1.36)0.004
Model 21.34 (1.16, 1.55)1.00 (reference)1.11 (0.90, 1.37)1.60 (1.30, 1.97)1.53 (1.17, 1.99)<0.001
Model 31.35 (1.16, 1.57)1.00 (reference)1.10 (0.89, 1.36)1.62 (1.32, 2.00)1.54 (1.18, 2.01)<0.001
* p for trend test was performed with the median value of each quartile treated as a continuous variable in the models. Model 1: unadjusted for any covariates. Model 2: adjusted for sex, age, race/ethnicity, marital status, education, poverty/income ratio, family history of hypertension, smoking status, alcohol consumption, average daily energy intake, physical activity, and BMI. Model 3: Model 2 plus self-reported CVD and diabetes.
Table 2. Odds ratios (95% CIs) for hypertension associated with LTL, NHANES 1999–2002.
Table 2. Odds ratios (95% CIs) for hypertension associated with LTL, NHANES 1999–2002.
Leukocyte Telomere LengthOR95% CIp Value
Model 10.260.19, 0.34<0.001
Model 20.620.45, 0.850.003
Model 30.650.47, 0.890.007
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Ouyang, C.; Yang, Y.; Pan, J.; Liu, H.; Wang, X.; Zhou, S.; Shi, X.; Zhang, Y.; Wang, D.; Hu, X. Leukocyte Telomere Length Mediates the Associations between Blood Lead and Cadmium with Hypertension among Adults in the United States: A Cross-Sectional Study. Toxics 2024, 12, 409. https://doi.org/10.3390/toxics12060409

AMA Style

Ouyang C, Yang Y, Pan J, Liu H, Wang X, Zhou S, Shi X, Zhang Y, Wang D, Hu X. Leukocyte Telomere Length Mediates the Associations between Blood Lead and Cadmium with Hypertension among Adults in the United States: A Cross-Sectional Study. Toxics. 2024; 12(6):409. https://doi.org/10.3390/toxics12060409

Chicago/Turabian Style

Ouyang, Changping, Yinan Yang, Jinhua Pan, Heming Liu, Xuemei Wang, Shengze Zhou, Xiaoru Shi, Yanxia Zhang, Dan Wang, and Xiaobin Hu. 2024. "Leukocyte Telomere Length Mediates the Associations between Blood Lead and Cadmium with Hypertension among Adults in the United States: A Cross-Sectional Study" Toxics 12, no. 6: 409. https://doi.org/10.3390/toxics12060409

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop